Endocrine News talks with Ghada El-Hajj Fuleihan, MD, MPH, and Matthew T. Drake, MD, PhD, co–chairs of the guideline development panel that created the latest Endocrine Society Clinical Practice Guideline on treating hypercalcemia of malignancy. Hypercalcemia of malignancy (HCM) is the most common metabolic complication of cancer, but its incidence may be declining due to […]
